Drugs Made in America Acquisition CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
DEF: Drugs Made in America Acquisition Corp. Seeks Shareholder Vote for Business Combination Extension
Drugs Made in America Acquisition Corp. is holding an extraordinary general meeting on April 27, 2026, to seek shareholder approval for an extension of its deadline to complete a business combination, proposing to move the termination date from April 29, 2026, to April 29, 2027.